Brad Barnett
Chief Tech/Sci/R&D Officer at COGENT BIOSCIENCES, INC.
Profile
Brad Barnett is currently the Chief Technology Officer at Cogent Biosciences, Inc. Prior to his current position, he worked at Array BioPharma, Inc. from 2000 to 2019, where he held the position of Vice President-Supply Chain & Manufacturing from 2015 to 2019.
Mr. Barnett received an undergraduate degree from Colorado State University and an MBA from The University of Colorado.
Brad Barnett active positions
Companies | Position | Start |
---|---|---|
COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Brad Barnett
Companies | Position | End |
---|---|---|
ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/08/2019 |
Training of Brad Barnett
Colorado State University | Undergraduate Degree |
The University of Colorado | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
COGENT BIOSCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Stock Market
- Insiders
- Brad Barnett